PlainRecalls
FDA Devices Moderate Class II Terminated

G8 Automated HPLC Analyzer - 723G8 Product Usage - In vitro diagnostic use for the quantitative measurement of % hemoglobin A1c in whole blood specimens. This test is to be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes.

Reported: October 3, 2018 Initiated: July 13, 2018 #Z-3244-2018

Product Description

G8 Automated HPLC Analyzer - 723G8 Product Usage - In vitro diagnostic use for the quantitative measurement of % hemoglobin A1c in whole blood specimens. This test is to be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes.

Reason for Recall

Analyzers were distributed with software which lacks a 510K

Details

Recalling Firm
Tosoh Bioscience Inc
Units Affected
8 units
Distribution
US Nationwide Distribution in states of - CA, OK, VA 7 WI
Location
Grove City, OH

Frequently Asked Questions

What product was recalled?
G8 Automated HPLC Analyzer - 723G8 Product Usage - In vitro diagnostic use for the quantitative measurement of % hemoglobin A1c in whole blood specimens. This test is to be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes.. Recalled by Tosoh Bioscience Inc. Units affected: 8 units.
Why was this product recalled?
Analyzers were distributed with software which lacks a 510K
Which agency issued this recall?
This recall was issued by the FDA Devices on October 3, 2018. Severity: Moderate. Recall number: Z-3244-2018.